← All indications
Epistaxis
Bleeding from the nose.
Drugs by status
Phase 3 trials (3)
Phase 2 trials (6)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (10)
- Unity Health Toronto
- University of Pavia
- University of Toronto
- University of California, San Diego
- University of Vienna
- Department of Defense
- Mercy Health Partners, Cincinnati
- University of North Carolina at Chapel Hill
- Washington University in St. Louis
- Hereditary Hemorrhagic Telangiectasia Foundation International
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (7)